Fundz

ILiAD Biotechnologies Announces Innovation Passport Designation for BPZE1 Next Generation Intranasal Pertussis Vaccine

Dec 04, 2024
WestonBiotechnology

Product Description

ILiAD Biotechnologies has received the Innovation Passport designation from the U.K. MHRA for BPZE1, an intranasal pertussis vaccine, designed to improve immunization against whooping cough. This vaccine aims to address the shortcomings of current vaccines in preventing B. pertussis colonization and transmission.

Company Information

Company

ILiAD Biotechnologies

Location

4581 Weston Road, Suite 260

Weston, Florida, United States

About

ILiAD Biotechnologies is a [Phase 3 ready] clinical-stage biotech company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis and other respiratory diseases.

Fundz sees it the moment ILiAD Biotechnologies ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Luis hidden

hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ILiAD Biotechnologies's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

ILiAD Biotechnologies shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.